Advancing CAR T Cell Research and Development

How to develop the best CAR T cell product for preclinical use.

Chimeric antigen receptor (CAR) T cells are genetically modified cell therapy products targeted to kill tumor cells. Their development and manufacturing require stringent quality control assessments at every workflow step. Researchers tackle these challenges using cutting-edge technologies to bring top-notch products to clinics. 

Download this ebook from Bio-Rad to learn about key devices that facilitate high-quality cell therapy product development. 

Sponsored by